CGC Stock Analysis: Buy, Sell, or Hold?
CGC - Canopy Growth Corporation Common Shares
$1.05
0.00 (0.00%)
▲
5d:
+2.94%
30d:
+16.01%
90d:
-1.87%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 07, 2026
0d
Get Alerted When CGC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CGC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CGC shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CGC is currently trading at $1.05, which is considered extended relative to its 30-day fair value range of $0.91 to $1.00. From a valuation perspective, the stock is trading at a discount (Forward PE: -4.1) compared to its historical average (13.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CGC is in a downtrend. The price is approaching resistance at $1.08. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CGC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.23 (+17.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CGC is in a downtrend. The price is approaching resistance at $1.08. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CGC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.23 (+17.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.91 -
$1.00
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
26.2%
Protect Your Profits
Holding CGC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.0% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($1.23)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.91 -
$1.00
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.94
Resistance Level
$1.08
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.10
Wall Street Target
$1.23
(+17.6%)
Revenue Growth (YoY)
12.5%
Profit Margin
-79.2%
PE vs Historical
-4.1 vs 13.0
CHEAP
Share & Embed Analysis
Last updated: August 23, 2026 10:09 PM ET
Data refreshes hourly during market hours. Next update: 11:09 PM
Data refreshes hourly during market hours. Next update: 11:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Joseph Bayern
SELL
2658 shares
2026-03-31
M Shan Atkins
SELL
2074 shares
2026-03-31
Theresa Yanofsky
SELL
10373 shares
2026-03-31
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$212 | 67 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 56 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$101 | 43 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 48 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 55 HOLD |
Advanced CGC Option Strategies
Professional options setups generated by AI based on today's CGC price and gamma walls.
